dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
Published 7 years ago • 39 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
6:00
use of immune checkpoint inhibitors for bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:35
dr. plimack on choosing a checkpoint inhibitor in bladder cancer
-
44:56
immune checkpoint blockade in cancer therapy
-
48:37
advanced treatment innovations in bladder cancer
-
6:31
what are checkpoint inhibitors?
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
4:51
practical considerations with checkpoint inhibitors in bladder cancer
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
1:06
dr. o'donnell compares checkpoint inhibitors in bladder cancer
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
1:11
daniel petrylak, md, on treating bladder cancer patients progressing on checkpoint inhibitors
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:41
dr. petrylak on immunotherapy for second-line treatment in bladder cancer
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
0:55
dr. plimack on frontline checkpoint inhibitors in bladder cancer